5-Azacitidine in patients with IDH1/2-mutant recurrent glioma

Federici Laetitia; Capelle Laurent; Annereau Maxime; Bielle Franck; Willekens Christophe; Dehais Caroline; Laigle-Donadey Florence; Hoang-Xuan Khe; Delattre Jean-Yves; Idbaih Ahmed; Lemare Francois; de Botton Stephane; Sanson Marc; Touat Mehdi

首页> 外文期刊>Neuro-Oncology >5-Azacitidine in patients with IDH1/2-mutant recurrent glioma

【24h】

5-Azacitidine in patients with IDH1/2-mutant recurrent glioma

机译：IDH1 / 2-突变反复性胶质瘤患者的5-氮己啶

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Neuro-Oncology》 |2020年第8期|1226-1228|共3页
作者
Federici Laetitia; Capelle Laurent; Annereau Maxime; Bielle Franck; Willekens Christophe; Dehais Caroline; Laigle-Donadey Florence; Hoang-Xuan Khe; Delattre Jean-Yves; Idbaih Ahmed; Lemare Francois; de Botton Stephane; Sanson Marc; Touat Mehdi;
展开▼
作者单位

Paris Saclay Univ Pharm Clin Serv Gustave Roussy Canc Campus Villejuif France;

Univ Hosp Pitie Salpetriere Charles Foix Dept Neurosurg Paris France;

Paris Saclay Univ Pharm Clin Serv Gustave Roussy Canc Campus Villejuif France;

Sorbonne Univ Inst Brain & Spinal Cord Dept Neurosurg Univ Hosp Pitie Salpetriere Charles Foix Neuropat Paris France;

Univ Paris Saclay Gustave Roussy Dept Hematol F-94805 Villejuif France|Paris Saclay Univ INSERM Unit 1170 Gustave Roussy Canc Campus Villejuif France;

Sorbonne Univ Inst Brain & Spinal Cord Univ Hosp Pitie Salpetriere Charles Foix Dept Neurosurg Neurol Serv 2 Mazarin Paris France;

Sorbonne Univ Inst Brain & Spinal Cord Univ Hosp Pitie Salpetriere Charles Foix Dept Neurosurg Neurol Serv 2 Mazarin Paris France;

Sorbonne Univ Inst Brain & Spinal Cord Univ Hosp Pitie Salpetriere Charles Foix Dept Neurosurg Neurol Serv 2 Mazarin Paris France;

Sorbonne Univ Inst Brain & Spinal Cord Univ Hosp Pitie Salpetriere Charles Foix Dept Neurosurg Neurol Serv 2 Mazarin Paris France;

Sorbonne Univ Inst Brain & Spinal Cord Univ Hosp Pitie Salpetriere Charles Foix Dept Neurosurg Neurol Serv 2 Mazarin Paris France;

Paris Saclay Univ Pharm Clin Serv Gustave Roussy Canc Campus Villejuif France;

Univ Paris Saclay Gustave Roussy Dept Hematol F-94805 Villejuif France|Paris Saclay Univ INSERM Unit 1170 Gustave Roussy Canc Campus Villejuif France;

Sorbonne Univ Inst Brain & Spinal Cord Univ Hosp Pitie Salpetriere Charles Foix Dept Neurosurg Neurol Serv 2 Mazarin Paris France;

Sorbonne Univ Inst Brain & Spinal Cord Univ Hosp Pitie Salpetriere Charles Foix Dept Neurosurg Neurol Serv 2 Mazarin Paris France|Harvard Med Sch Dana Farber Canc Inst Dept Oncol Pathol Boston MA 02115 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
入库时间 2022-08-18 23:31:58

相似文献

外文文献
中文文献
专利

1. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. [J] . Hartmann C, Hentschel B, Wick W, Acta Neuropathologica . 2010,第6期

机译：与IDH1突变的胶质母细胞瘤相比，IDH1野生型间变性星形细胞瘤的患者预后较差，IDH1突变状态说明了较高年龄的不良预后效应：对神经胶质瘤分类的影响。
2. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas [J] . Christian Hartmann, Bettina Hentschel, Wolfgang Wick, Acta Neuropathologica . 2010,第6期

机译：与IDH1突变的胶质母细胞瘤相比，IDH1野生型间变性星形细胞瘤的患者预后较差，IDH1突变状态说明了较高年龄的不良预后效应：对神经胶质瘤分类的影响
3. Correlation between IDH1 gene mutation status and survival of patients treated for recurrent glioma. [J] . Lv S, Teugels E, Sadones J, Anticancer Research: International Journal of Cancer Research and Treatment . 2011,第12期

机译：IDH1基因突变状态与复发性神经胶质瘤患者生存率的相关性。
4. Multi-label Inductive Matrix Completion for Joint MGMT and IDH1 Status Prediction for Glioma Patients [C] . Lei Chen, Han Zhang, Kim-Han Thung, International conference on medical imaging computing and computer-assisted intervention . 2017

机译：胶质瘤患者的MGMT和IDH1联合状态预测的多标签感应矩阵完成
5. Predicting Isocitrate Dehydrogenase 1 (IDH1) Mutation in Patients with Gliomas using a Novel Deep Learning Network [D] . Xiao, Haonan. 2019

机译：使用小说深入学习网络预测胶质瘤患者的异偶酯脱氢酶1（IDH1）突变
6. 5-Azacitidine in patients with IDH1/2-mutant recurrent glioma [O] . Laetitia Federici, Laurent Capelle, Maxime Annereau, 2020

机译：IDH1 / 2-突变反复性胶质瘤患者的5-氮己啶
7. ACTR-46. AG120, A FIRST-IN-CLASS MUTANT IDH1 INHIBITOR IN PATIENTS WITH RECURRENT OR PROGRESSIVE IDH1 MUTANT GLIOMA: RESULTS FROM THE PHASE 1 GLIOMA EXPANSION COHORTS [O] . Ingo K. Mellinghoff, Mehdi Touat, Elizabeth Maher, 2016

机译：ACTR-46。 AG120，一种复发性或渐进式IDH1突变胶质瘤患者的一类突变体IDH1抑制剂：1型胶质瘤扩张队列的结果

5-Azacitidine in patients with IDH1/2-mutant recurrent glioma

著录项

相似文献

相关主题

期刊订阅